Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approach

The life-threatening consequences of acquired, or drug-induced, long QT syndrome due to block of the human ether-a-go-go-related gene (hERG) channel are well appreciated and have been the cause of several drugs being removed from the market in recent years because of patient death. In the last decad...

Full description

Saved in:

Bibliographic Details
Published in:	Assay and drug development technologies Vol. 6; no. 2; p. 213
Main Authors:	Piper, David R, Duff, Steve R, Eliason, Hildegard C, Frazee, W Jack, Frey, Elizabeth A, Fuerstenau-Sharp, Maya, Jachec, Christine, Marks, Bryan D, Pollok, Brian A, Shekhani, Mohammed Saleh, Thompson, David V, Whitney, Pam, Vogel, Kurt W, Hess, Stephen D
Format:	Journal Article
Language:	English
Published:	United States 01-04-2008
Subjects:	CD8 Antigens - physiology Cell Line Cell Membrane - drug effects Cell Membrane - metabolism Data Interpretation, Statistical Drug Evaluation, Preclinical - methods Electrophysiology Ether-A-Go-Go Potassium Channels - drug effects Ether-A-Go-Go Potassium Channels - metabolism Flow Cytometry Fluorescence Polarization - methods Fluorescent Dyes Genetic Engineering Humans Immunohistochemistry Membrane Potentials - physiology Membrane Proteins - physiology Patch-Clamp Techniques Radioligand Assay
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The life-threatening consequences of acquired, or drug-induced, long QT syndrome due to block of the human ether-a-go-go-related gene (hERG) channel are well appreciated and have been the cause of several drugs being removed from the market in recent years because of patient death. In the last decade, the propensity for block of the hERG channel by a diverse and expanding set of compounds has led to the requirement that all new drugs be tested for hERG channel block in a functional patch-clamp assay. Because of the need to identify potential hERG blockers early in the discovery process, radiometric hERG binding assays are preferred over patch-clamp assays for compound triage, because of relative advantages in speed and cost. Even so, these radiometric binding assays are laborious and require dedicated instrumentation and infrastructure to cope with the regulatory and safety issues associated with the use of radiation. To overcome these limitations, we developed a homogeneous, fluorescence polarization-based assay to identify and characterize the affinity of small molecules for the hERG channel and have demonstrated tight correlation with data obtained from either radioligand binding or patch-clamp assays. Key to the development of this assay was a cell line that expressed highly elevated levels of hERG protein, which was generated by coupling expression of the hERG channel to that of a selectable cell surface marker. A high-expressing clone was isolated by flow cytometry and used to generate membrane preparations that contained >50-fold the typical density of hERG channels measured by [(3)H]astemizole binding. This strategy enabled the Predictor (Invitrogen, Carlsbad, CA) hERG fluorescence polarization assay and should be useful in the development of other fluorescence polarization-based assays that use membrane proteins.
ISSN:	1540-658X
DOI:	10.1089/adt.2008.137